Skip to main content
Erschienen in: Esophagus 2/2013

01.06.2013 | Original Article

Estimation of physiologic ability and surgical stress (E-PASS) can assess short-term outcome after esophagectomy for esophageal cancer

verfasst von: Naoya Yoshida, Masayuki Watanabe, Yoshifumi Baba, Shiro Iwagami, Takatsugu Ishimoto, Masaaki Iwatsuki, Yasuo Sakamoto, Yuji Miyamoto, Nobuyuki Ozaki, Hideo Baba

Erschienen in: Esophagus | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Postoperative morbidity after esophagectomy for esophageal cancer is still frequent. Tools for prediction of postoperative complications have been sought, with the estimation of physiologic ability and surgical stress (E-PASS) scoring system being one of the candidates. The aim of this study was to determine the usefulness of the E-PASS system for risk assessment of esophagectomy.

Methods

The clinical courses of 308 patients who underwent elective subtotal esophagectomy with lymph node dissection for esophageal cancer were analyzed. The incidence and severity of complication and influence of preoperative therapy were investigated using the E-PASS system.

Results

The incidence of any complication was as high as 42.2 %. The frequency of severe and critical complications was 13.0 and 6.8 %, respectively. The E-PASS system could estimate the incidence and severity of complications. Patients with a comprehensive risk score (CRS) >0.9 had a significantly higher probability of incidence of severe or critical complications. The incidence of complication and the CRS increased linearly according to preoperative treatment in the following order: no preoperative treatment < neoadjuvant chemotherapy < neoadjuvant chemoradiotherapy < definitive chemoradiotherapy. These were significantly higher after salvage esophagectomy.

Conclusion

The E-PASS scoring system was useful for risk assessment after esophagectomy. Patients with a CRS >0.9 and patients undergoing salvage esophagectomy should be treated carefully after surgery. Among two scoring systems of which the CRS consisted, the surgical stress score strongly correlated with postoperative complications after esophagectomy, but the preoperative risk score did not.
Literatur
1.
Zurück zum Zitat Bakhos CT, Fabian T, Oyasiji TO, Gautam S, Gangadharan SP, Kent MS, et al. Impact of the surgical technique on pulmonary morbidity after esophagectomy. Ann Thorac Surg. 2012;93:221–6.PubMedCrossRef Bakhos CT, Fabian T, Oyasiji TO, Gautam S, Gangadharan SP, Kent MS, et al. Impact of the surgical technique on pulmonary morbidity after esophagectomy. Ann Thorac Surg. 2012;93:221–6.PubMedCrossRef
2.
Zurück zum Zitat Schieman C, Wigle DA, Deschamps C, Nichols Iii FC, Cassivi SD, Shen KR, et al. Patterns of operative mortality following esophagectomy. Dis Esophagus. 2012;25:645–51.PubMedCrossRef Schieman C, Wigle DA, Deschamps C, Nichols Iii FC, Cassivi SD, Shen KR, et al. Patterns of operative mortality following esophagectomy. Dis Esophagus. 2012;25:645–51.PubMedCrossRef
3.
Zurück zum Zitat Ferguson MK, Celauro AD, Prachand V. Assessment of a scoring system for predicting complications after esophagectomy. Dis Esophagus. 2011;24:510–5.PubMedCrossRef Ferguson MK, Celauro AD, Prachand V. Assessment of a scoring system for predicting complications after esophagectomy. Dis Esophagus. 2011;24:510–5.PubMedCrossRef
4.
Zurück zum Zitat Paul DJ, Jamieson GG, Watson DI, Devitt PG, Game PA. Perioperative risk analysis for acute respiratory distress syndrome after elective oesophagectomy. ANZ J Surg. 2011;81:700–6.PubMedCrossRef Paul DJ, Jamieson GG, Watson DI, Devitt PG, Game PA. Perioperative risk analysis for acute respiratory distress syndrome after elective oesophagectomy. ANZ J Surg. 2011;81:700–6.PubMedCrossRef
5.
Zurück zum Zitat Valentí V, Hernández-Lizoain JL, Marínez-Regueira F, Bellver M, Rodríguez J, Díaz González JA, et al. Transthoracic oesophagectomy with lymphadenectomy in 100 oesophageal cancer patients: multidisciplinary approach. Clin Transl Oncol. 2011;13:899–903.PubMedCrossRef Valentí V, Hernández-Lizoain JL, Marínez-Regueira F, Bellver M, Rodríguez J, Díaz González JA, et al. Transthoracic oesophagectomy with lymphadenectomy in 100 oesophageal cancer patients: multidisciplinary approach. Clin Transl Oncol. 2011;13:899–903.PubMedCrossRef
6.
Zurück zum Zitat Dutta S, Al-Mrabt NM, Fullarton GM, Horgan PG, McMillan DC. A comparison of POSSUM and GPS models in the prediction of post-operative outcome in patients undergoing oesophago-gastric cancer resection. Ann Surg Oncol. 2011;18:2808–17.PubMedCrossRef Dutta S, Al-Mrabt NM, Fullarton GM, Horgan PG, McMillan DC. A comparison of POSSUM and GPS models in the prediction of post-operative outcome in patients undergoing oesophago-gastric cancer resection. Ann Surg Oncol. 2011;18:2808–17.PubMedCrossRef
7.
Zurück zum Zitat Grotenhuis BA, van Hagen P, Reitsma JB, Lagarde SM, Wijnhoven BP, van Berge Henegouwen MI, et al. Validation of a nomogram predicting complications after esophagectomy for cancer. Ann Thorac Surg. 2010;90:920–5.PubMedCrossRef Grotenhuis BA, van Hagen P, Reitsma JB, Lagarde SM, Wijnhoven BP, van Berge Henegouwen MI, et al. Validation of a nomogram predicting complications after esophagectomy for cancer. Ann Thorac Surg. 2010;90:920–5.PubMedCrossRef
8.
Zurück zum Zitat Dhungel B, Diggs BS, Hunter JG, Sheppard BC, Vetto JT, Dolan JP. Patient and peri-operative predictors of morbidity and mortality after esophagectomy: American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), 2005–2008. J Gastrointest Surg. 2010;14:1492–501.PubMedCrossRef Dhungel B, Diggs BS, Hunter JG, Sheppard BC, Vetto JT, Dolan JP. Patient and peri-operative predictors of morbidity and mortality after esophagectomy: American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), 2005–2008. J Gastrointest Surg. 2010;14:1492–501.PubMedCrossRef
9.
Zurück zum Zitat Wright CD, Kucharczuk JC, O’Brien SM, Grab JD, Allen MS. Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk adjustment model. J Thorac Cardiovasc Surg. 2009;137:587–95.PubMedCrossRef Wright CD, Kucharczuk JC, O’Brien SM, Grab JD, Allen MS. Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk adjustment model. J Thorac Cardiovasc Surg. 2009;137:587–95.PubMedCrossRef
10.
Zurück zum Zitat Lagarde SM, Reitsma JB, Maris AK, van Berge Henegouwen MI, Busch OR, Obertop H, et al. Preoperative prediction of the occurrence and severity of complications after esophagectomy for cancer with use of a nomogram. Ann Thorac Surg. 2008;85:1938–45.PubMedCrossRef Lagarde SM, Reitsma JB, Maris AK, van Berge Henegouwen MI, Busch OR, Obertop H, et al. Preoperative prediction of the occurrence and severity of complications after esophagectomy for cancer with use of a nomogram. Ann Thorac Surg. 2008;85:1938–45.PubMedCrossRef
11.
Zurück zum Zitat Thompson AM, Rapson T, Gilbert FJ, Park KG. Hospital volume does not influence long-term survival of patients undergoing surgery for oesophageal or gastric cancer. Br J Surg. 2007;94:578–84.PubMedCrossRef Thompson AM, Rapson T, Gilbert FJ, Park KG. Hospital volume does not influence long-term survival of patients undergoing surgery for oesophageal or gastric cancer. Br J Surg. 2007;94:578–84.PubMedCrossRef
12.
Zurück zum Zitat Rodgers M, Jobe BA, O’Rourke RW, Sheppard B, Diggs B, Hunter JG. Case volume as a predictor of inpatient mortality after esophagectomy. Arch Surg. 2007;142:829–39.PubMedCrossRef Rodgers M, Jobe BA, O’Rourke RW, Sheppard B, Diggs B, Hunter JG. Case volume as a predictor of inpatient mortality after esophagectomy. Arch Surg. 2007;142:829–39.PubMedCrossRef
13.
Zurück zum Zitat Sunpaweravong S, Ruangsin S, Laohawiriyakamol S, Mahattanobon S, Geater A. Prediction of major postoperative complications and survival for locally advanced esophageal carcinoma patients. Asian J Surg. 2012;35:104–9.PubMedCrossRef Sunpaweravong S, Ruangsin S, Laohawiriyakamol S, Mahattanobon S, Geater A. Prediction of major postoperative complications and survival for locally advanced esophageal carcinoma patients. Asian J Surg. 2012;35:104–9.PubMedCrossRef
14.
Zurück zum Zitat Grotenhuis BA, Wijnhoven BP, Grüne F, van Bommel J, Tilanus HW, van Lanschot JJ. Preoperative risk assessment and prevention of complications in patients with esophageal cancer. J Surg Oncol. 2010;101:270–8.PubMed Grotenhuis BA, Wijnhoven BP, Grüne F, van Bommel J, Tilanus HW, van Lanschot JJ. Preoperative risk assessment and prevention of complications in patients with esophageal cancer. J Surg Oncol. 2010;101:270–8.PubMed
15.
Zurück zum Zitat Noble F, Curtis N, Harris S, Kelly JJ, Bailey IS, Byrne JP, et al. Risk assessment using a novel score to predict anastomotic leak and major complications after oesophageal resection. J Gastrointest Surg. 2012;16:1083–95.PubMedCrossRef Noble F, Curtis N, Harris S, Kelly JJ, Bailey IS, Byrne JP, et al. Risk assessment using a novel score to predict anastomotic leak and major complications after oesophageal resection. J Gastrointest Surg. 2012;16:1083–95.PubMedCrossRef
16.
Zurück zum Zitat Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.PubMedCrossRef Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.PubMedCrossRef
17.
Zurück zum Zitat Haga Y, Ikei S, Ogawa M. Estimation of physiologic ability and surgical stress (E-PASS) as a new prediction scoring system for postoperative morbidity and mortality following elective gastrointestinal surgery. Surg Today. 1999;29:219–25.PubMedCrossRef Haga Y, Ikei S, Ogawa M. Estimation of physiologic ability and surgical stress (E-PASS) as a new prediction scoring system for postoperative morbidity and mortality following elective gastrointestinal surgery. Surg Today. 1999;29:219–25.PubMedCrossRef
18.
Zurück zum Zitat Copeland GP, Jones D, Walters M. POSSUM: a scoring system for surgical audit. Br J Surg. 1991;78:355–60.PubMedCrossRef Copeland GP, Jones D, Walters M. POSSUM: a scoring system for surgical audit. Br J Surg. 1991;78:355–60.PubMedCrossRef
19.
Zurück zum Zitat McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc. 2008;67:257–62.PubMedCrossRef McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc. 2008;67:257–62.PubMedCrossRef
20.
Zurück zum Zitat Baba Y, Haga Y, Hiyoshi Y, Imamura Y, Nagai Y, Yoshida N, et al. Estimation of physiologic ability and surgical stress (E-PASS system) in patients with esophageal squamous cell carcinoma undergoing resection. Esophagus. 2008;5:81–6.CrossRef Baba Y, Haga Y, Hiyoshi Y, Imamura Y, Nagai Y, Yoshida N, et al. Estimation of physiologic ability and surgical stress (E-PASS system) in patients with esophageal squamous cell carcinoma undergoing resection. Esophagus. 2008;5:81–6.CrossRef
21.
Zurück zum Zitat Haga Y, Wada Y, Takeuchi H, Ikejiri K, Ikenaga M, Kimura O. Evaluation of modified estimation of physiologic ability and surgical stress in gastric carcinoma surgery. Gastric Cancer. 2012;15:7–14.PubMedCrossRef Haga Y, Wada Y, Takeuchi H, Ikejiri K, Ikenaga M, Kimura O. Evaluation of modified estimation of physiologic ability and surgical stress in gastric carcinoma surgery. Gastric Cancer. 2012;15:7–14.PubMedCrossRef
22.
Zurück zum Zitat Haga Y, Wada Y, Ikenaga M, Takeuchi H, Ikejiri K. Evaluation of modified estimation of physiologic ability and surgical stress in colorectal carcinoma surgery. Dis Colon Rectum. 2011;54:1293–300.PubMedCrossRef Haga Y, Wada Y, Ikenaga M, Takeuchi H, Ikejiri K. Evaluation of modified estimation of physiologic ability and surgical stress in colorectal carcinoma surgery. Dis Colon Rectum. 2011;54:1293–300.PubMedCrossRef
23.
Zurück zum Zitat Hashimoto D, Takamori H, Sakamoto Y, Ikuta Y, Nakahara O, Furuhashi S, et al. Is an estimation of physiologic ability and surgical stress able to predict operative morbidity after pancreaticoduodenectomy? J Hepatobiliary Pancreat Sci. 2010;17:132–8.PubMedCrossRef Hashimoto D, Takamori H, Sakamoto Y, Ikuta Y, Nakahara O, Furuhashi S, et al. Is an estimation of physiologic ability and surgical stress able to predict operative morbidity after pancreaticoduodenectomy? J Hepatobiliary Pancreat Sci. 2010;17:132–8.PubMedCrossRef
24.
Zurück zum Zitat Hashimoto D, Takamori H, Sakamoto Y, Tanaka H, Hirota M, Baba H. Can the physiologic ability and surgical stress (E-PASS) scoring system predict operative morbidity after distal pancreatectomy? Surg Today. 2010;40:632–7.PubMedCrossRef Hashimoto D, Takamori H, Sakamoto Y, Tanaka H, Hirota M, Baba H. Can the physiologic ability and surgical stress (E-PASS) scoring system predict operative morbidity after distal pancreatectomy? Surg Today. 2010;40:632–7.PubMedCrossRef
25.
Zurück zum Zitat Watanabe M, Nagai Y, Kinoshita K, Saito S, Kurashige J, Karashima R, et al. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for patients with node-positive esophageal cancer. Digestion. 2011;83:146–52.PubMedCrossRef Watanabe M, Nagai Y, Kinoshita K, Saito S, Kurashige J, Karashima R, et al. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for patients with node-positive esophageal cancer. Digestion. 2011;83:146–52.PubMedCrossRef
26.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.PubMedCrossRef Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.PubMedCrossRef
27.
Zurück zum Zitat Watanabe M, Yoshida N, Karashima R, Sato N, Hirashima K, Imamura Y, et al. Transcervical superior mediastinal lymph node dissection combined with transhiatal lower esophageal dissection before transthoracic esophagectomy: a safe approach for salvage esophagectomy. J Am Coll Surg. 2009;208:e7–9.PubMedCrossRef Watanabe M, Yoshida N, Karashima R, Sato N, Hirashima K, Imamura Y, et al. Transcervical superior mediastinal lymph node dissection combined with transhiatal lower esophageal dissection before transthoracic esophagectomy: a safe approach for salvage esophagectomy. J Am Coll Surg. 2009;208:e7–9.PubMedCrossRef
28.
Zurück zum Zitat Nakamura M, Iwahashi M, Nakamori M, Ishida K, Naka T, Iida T, et al. An analysis of the factors contributing to a reduction in the incidence of pulmonary complications following an esophagectomy for esophageal cancer. Langenbecks Arch Surg. 2008;393:127–33.PubMedCrossRef Nakamura M, Iwahashi M, Nakamori M, Ishida K, Naka T, Iida T, et al. An analysis of the factors contributing to a reduction in the incidence of pulmonary complications following an esophagectomy for esophageal cancer. Langenbecks Arch Surg. 2008;393:127–33.PubMedCrossRef
29.
Zurück zum Zitat Law S, Wong KH, Kwok KF, Chu KM, Wong J. Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg. 2004;240:791–800.PubMedCrossRef Law S, Wong KH, Kwok KF, Chu KM, Wong J. Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg. 2004;240:791–800.PubMedCrossRef
30.
Zurück zum Zitat Morita M, Kumashiro R, Hisamatsu Y, Nakanishi R, Egashira A, Saeki H, et al. Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy. J Gastroenterol. 2011;46:1284–91.PubMedCrossRef Morita M, Kumashiro R, Hisamatsu Y, Nakanishi R, Egashira A, Saeki H, et al. Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy. J Gastroenterol. 2011;46:1284–91.PubMedCrossRef
31.
Zurück zum Zitat Takeuchi H, Saikawa Y, Oyama T, Ozawa S, Suda K, Wada N, et al. Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy. World J Surg. 2010;34:277–84.PubMedCrossRef Takeuchi H, Saikawa Y, Oyama T, Ozawa S, Suda K, Wada N, et al. Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy. World J Surg. 2010;34:277–84.PubMedCrossRef
32.
Zurück zum Zitat Miyata H, Yamasaki M, Takiguchi S, Nakajima K, Fujiwara Y, Nishida T, et al. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer. J Surg Oncol. 2009;100:442–6.PubMedCrossRef Miyata H, Yamasaki M, Takiguchi S, Nakajima K, Fujiwara Y, Nishida T, et al. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer. J Surg Oncol. 2009;100:442–6.PubMedCrossRef
33.
Zurück zum Zitat Tachimori Y, Kanamori N, Uemura N, Hokamura N, Igaki H, Kato H. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 2009;137:49–54.PubMedCrossRef Tachimori Y, Kanamori N, Uemura N, Hokamura N, Igaki H, Kato H. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 2009;137:49–54.PubMedCrossRef
34.
Zurück zum Zitat Chao YK, Chan SC, Chang HK, Liu YH, Wu YC, Hsieh MJ, et al. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus. Eur J Surg Oncol. 2009;35:289–94.PubMedCrossRef Chao YK, Chan SC, Chang HK, Liu YH, Wu YC, Hsieh MJ, et al. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus. Eur J Surg Oncol. 2009;35:289–94.PubMedCrossRef
35.
Zurück zum Zitat Schlag PM. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group. Arch Surg. 1992;127:1446–50.PubMedCrossRef Schlag PM. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group. Arch Surg. 1992;127:1446–50.PubMedCrossRef
Metadaten
Titel
Estimation of physiologic ability and surgical stress (E-PASS) can assess short-term outcome after esophagectomy for esophageal cancer
verfasst von
Naoya Yoshida
Masayuki Watanabe
Yoshifumi Baba
Shiro Iwagami
Takatsugu Ishimoto
Masaaki Iwatsuki
Yasuo Sakamoto
Yuji Miyamoto
Nobuyuki Ozaki
Hideo Baba
Publikationsdatum
01.06.2013
Verlag
Springer Japan
Erschienen in
Esophagus / Ausgabe 2/2013
Print ISSN: 1612-9059
Elektronische ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-013-0369-5

Weitere Artikel der Ausgabe 2/2013

Esophagus 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.